Medical Device Network on MSN
FDA clears Varian’s TrueBeam systems for low-dose radiation therapy in osteoarthritis
Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients ...
Siemens Healthineers announced that its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam ...
Leading integrated radiotherapy systems maker Varian Medical (VAR) has secured the approval of the U.S. Food and Drug Administration (FDA) for its novel Proton Therapy System, which delivers protons ...
PALO ALTO, Calif., March 17, 2020 /PRNewswire/ -- Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam ® Compact proton ...
The MarketWatch News Department was not involved in the creation of this content. -- Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies -- Collaboration between ...
The "United States Proton Therapy Market Report Forecast by Indication. States and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Proton Therapy ...
Ensuring the proper identification and positioning of a patient during radiation treatment is essential. Now, proton therapy player Varian Medical Systems Inc. has acquired Munich, Germany-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results